These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11949122)

  • 1. Pharmaceutical excipients.
    Noerr B
    Neonatal Netw; 2000 Sep; 19(6):67-70. PubMed ID: 11949122
    [No Abstract]   [Full Text] [Related]  

  • 2. Excipient exposure in very low birth weight preterm neonates.
    Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
    J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of "inert" additives or excipients in paediatric medicines.
    Nahata MC
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
    [No Abstract]   [Full Text] [Related]  

  • 4. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
    Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
    Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylene glycol: an often unrecognized cause of allergic contact dermatitis in patients using topical corticosteroids.
    Al Jasser M; Mebuke N; de Gannes GC
    Skin Therapy Lett; 2011 May; 16(5):5-7. PubMed ID: 21611683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe excipient exposure in neonates and small children - protocol for the SEEN project.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic management of a patient with an allergy to propylene glycol and parabens.
    Farber MK; Angelo TE; Castells M; Tsen LC
    Anesth Analg; 2010 Mar; 110(3):839-42. PubMed ID: 20185660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing practices in the use of benzyl alcohol-preserved solutions in neonatal intensive care units in Georgia.
    Jarvis WR; Sikes RK
    J Med Assoc Ga; 1983 Oct; 72(10):707-8. PubMed ID: 6644194
    [No Abstract]   [Full Text] [Related]  

  • 11. Benzyl alcohol: toxic agent in neonatal units.
    Pediatrics; 1983 Sep; 72(3):356-8. PubMed ID: 6889041
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
    Stjepanovic AN; Todorovic NB; Tesic TZ; Komazec ZS; Canji-Panic JM; Lalic-Popovic MN
    Regul Toxicol Pharmacol; 2022 Aug; 133():105225. PubMed ID: 35817211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of short-term propylene glycol tolerance in neonates.
    Allegaert K; Vanhaesebrouck S; Kulo A; Cosaert K; Verbesselt R; Debeer A; de Hoon J
    Arch Dis Child; 2010 Dec; 95(12):1054-8. PubMed ID: 20959360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in the newborn.
    Kumar SP
    Ann Clin Lab Sci; 1985; 15(3):195-203. PubMed ID: 2986513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biocompatibility of parenteral vehicles--in vitro/in vivo screening comparison and the effect of excipients on hemolysis.
    Fu RC; Lidgate DM; Whatley JL; McCullough T
    J Parenter Sci Technol; 1987; 41(5):164-8. PubMed ID: 3694339
    [No Abstract]   [Full Text] [Related]  

  • 17. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    Horinek EL; Kiser TH; Fish DN; MacLaren R
    Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical evaluation of steroidal ointments by ATR-IR chemical imaging: distribution of active and inactive pharmaceutical ingredients.
    Yamamoto Y; Fukami T; Koide T; Suzuki T; Hiyama Y; Tomono K
    Int J Pharm; 2012 Apr; 426(1-2):54-60. PubMed ID: 22286017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probable adverse reaction to a pharmaceutical excipient.
    Hall CM; Milligan DW; Berrington J
    Arch Dis Child Fetal Neonatal Ed; 2004 Mar; 89(2):F184. PubMed ID: 14977910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.